FEI announces adverse drug findings in two competition horses


The FEI has announced two new adverse findings in horses involving prohibited substances.

Samples taken at the CSIO2* in Tehran, Iran, late in September from the showjumping horse Sir de Diamant, ridden by Mohammad Davoud Shekofti, of Iran, were positive for the banned substance stanozolol and its metabolite, 16 beta hydroxy-stanozol. It is an anabolic steroid that promotes muscle mass.

The horse’s sample also tested positive for the controlled medication dexamethasone, a corticosteroid used to treat inflammatory and auto-immune conditions, and the non-steroidal anti-inflammatory drug flunixin.

Samples taken at the Young Horse Endurance Championships in Valeggio sul Minico, Italy, on September 26 from the horse Barbaforte Bosana, ridden by Camilla Malta, of Italy, have tested positive for the banned substance ergonovine, a vasoconstrictor.

Both athletes have been provisionally suspended from November 16 – the date of notification. The horses have been provisionally suspended for two months.

Support personnel

In a separate case, the FEI has notified Dr Pasha Syed Kamaal, of India, that a case has been opened against him as support personnel in the 2012 case of Glenmorgan.

Samples taken from the horse, which was ridden by Sheikh Hazza bin Sultan bin Zayed Al Nahyan, of the United Arab Emirates, in the CEI3* 160km endurance ride at Al Wathba, Abu Dhabi, on February 10, 2012, were positive for the banned substance propoxyphene, an opioid analgaesic, and its metabolite norpropoxyphene.

The FEI Tribunal had already imposed a 27-month suspension on the sheikh as the Person Responsible, which was reduced to 18 months on appeal to the Court of Arbitration for Sport (CAS).

During the FEI Tribunal and CAS proceedings, Dr Syed Kamaal made statements confirming that he had administered the product Fustex to the horse on the night before the event. Fustex contains propoxyphene, although it is not listed as an ingredient.

Dr Syed Kamaal has been provisionally suspended from November 16 – the date of notification – in advance of the case coming before the FEI Tribunal.

Final decisions

The FEI Tribunal has issued final decisions in the case of the horse Up Date 2, with sanctions imposed against the rider, horse owner and vet.

Samples taken from the horse at the CSI3* San Giovanni showjumping event in Marignano, Italy, on August 9, were positive for the banned substance stanozol.

A two-year period of ineligibility was imposed on the rider, Mariano Ossa, of Argentina, the Person Responsible (PR) under the FEI Equine Anti-Doping and Controlled Medication Regulations, from the date of sample collection.

However, the FEI Tribunal reduced the period of suspension by five months as his substantial help resulted in proceedings being opened against the horse owner and the vet.

As a result, he will be ineligible through to March 8, 2016. He was also fined 2000 Swiss Francs and ordered to pay 1000 Swiss Francs towards the legal costs of the judicial procedure.

Additionally, the horse has been disqualified from all placings at the event, as well as from all placings achieved since May 21, 2014, the date of administration of the banned substance.

The horse owner, Fabio Mazzarella, of Venezuela, and the FEI Permitted Treating Veterinarian, Dr William Yerkes, of the United States, were both charged under Article 2.2 of the FEI Equine Anti-Doping Regulations relating to use or attempted use of a banned substance.

A two-year period of ineligibility has been imposed on Yerkes, and a 19-month suspension for Mazzarella. Both periods of ineligibility have been backdated to May 21, 2014, the date when the banned substance was given to the horse. The owner has also been fined 5000 Swiss Francs.


Latest research and information from the horse world.

Leave a Reply

Your email address will not be published. Required fields are marked *